These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. Grundman M; Corey-Bloom J; Thal LJ J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663 [TBL] [Abstract][Full Text] [Related]
5. Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development. Cutler NR; Sramek JJ Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):27-57. PubMed ID: 11263756 [TBL] [Abstract][Full Text] [Related]
6. Perspectives of pharmacotherapy in Alzheimer's disease. Yamada K; Ren X; Nabeshima T Jpn J Pharmacol; 1999 May; 80(1):9-14. PubMed ID: 10446751 [TBL] [Abstract][Full Text] [Related]
7. Cognitive enhancement therapy for Alzheimer's disease. The way forward. Parnetti L; Senin U; Mecocci P Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the treatment of Alzheimer's. Richter RW; Farlow MR J Okla State Med Assoc; 1998 Nov; 91(8):431-7. PubMed ID: 9828525 [No Abstract] [Full Text] [Related]
9. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Cai Z Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484 [TBL] [Abstract][Full Text] [Related]
11. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
12. An update on primary drug therapies for Alzheimer disease. Knopman DS; Morris JC Arch Neurol; 1997 Nov; 54(11):1406-9. PubMed ID: 9362990 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. Prasad KN; Cole WC; Prasad KC J Am Coll Nutr; 2002 Dec; 21(6):506-22. PubMed ID: 12480796 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of Alzheimer's disease]. López OL; Becker JT Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Amenta F; Parnetti L; Gallai V; Wallin A Mech Ageing Dev; 2001 Nov; 122(16):2025-40. PubMed ID: 11589920 [TBL] [Abstract][Full Text] [Related]
17. Managing expectations in the long-term treatment of Alzheimer's disease. Gauthier S Gerontology; 1999; 45 Suppl 1():33-8. PubMed ID: 9876216 [TBL] [Abstract][Full Text] [Related]
18. New trends in the design of drugs against Alzheimer's disease. Francotte P; Graindorge E; Boverie S; de Tullio P; Pirotte B Curr Med Chem; 2004 Jul; 11(13):1757-78. PubMed ID: 15279580 [TBL] [Abstract][Full Text] [Related]
19. Current and future treatments for cognitive deficits in dementia. McLendon BM; Chen GG; Doraiswamy PM Curr Psychiatry Rep; 2000 Feb; 2(1):20-3. PubMed ID: 11122927 [TBL] [Abstract][Full Text] [Related]